Above studies collectively indicate the involvement of CIP2A during malignant progression of lung tumors and argue in favor of the fact that IL-10 may aid in promoting tumor aggressiveness via upregulation of CIP2A transcription in lung adenocarcinoma [44]. The gene discussed is CIP2A; the disease is lung adenocarcinoma.